title: Chorionic gonadotrophin and c-myc expression in growing and growth-inhibited (intermediate) trophoblasts.
abstract: FEG-3 cells are a clonal line of human choriocarcinoma and resemble villous cytotrophoblasts which are the stem cells for the syncytiotrophoblast in the placenta. FEG-3 cells synthesize and secrete the alpha subunit of human chorionic gonadotrophin (hCG). Treatment of FEG-3 cells with the chemotherapeutic drug (1 microM) methotrexate (MTX) results in an increase in nuclear diameter. Cell division is blocked and a decrease in c-myc mRNA levels in observed. The effects on cell growth and c-myc mRNA expression are reversible, and cells treated with MTX for 48 h retain their proliferative potential. Assessment of placental hormone gene expression reveals that a member of the human growth hormone gene family is expressed at extremely low levels and is unaffected by MTX treatment. Alpha and beta chorionic gonadotrophin (hCG) levels are increased by MTX treatment, but levels decrease following removal of MTX. In contrast to hCG in FEG-3 cells, non-trophoblastic or ectopic production of alpha hCG in human cervical carcinoma cells is inhibited by MTX treatment. These data indicate that MTX will induce morphological and biochemical changes in FEG-3 cells. They reveal an inverse relationship between c-myc and hCG RNA expression, and suggest different mechanisms govern trophoblast versus non-trophoblast production of alpha hCG.
authors.affiliation: Department of Physiology, University of Manitoba, Winnipeg, Canada.
authors.forename: M W
authors.initials: MW
authors.lastname: Nachtigal
authors.forename: M E
authors.initials: ME
authors.lastname: Bock
authors.forename: B A
authors.initials: BA
authors.lastname: Kowaluk
authors.forename: P A
authors.initials: PA
authors.lastname: Cattini
mesh_terms: D000199:Actins / Q000096:biosynthesis; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D002460:Cell Line; D002822:Choriocarcinoma / Q000378:metabolism; D006063:Chorionic Gonadotropin / Q000096:biosynthesis*; D004591:Electrophoresis, Polyacrylamide Gel; D015870:Gene Expression / Q000187:drug effects; D013006:Growth Hormone / Q000096:biosynthesis; D006367:HeLa Cells / Q000378:metabolism; D006801:Humans; D008727:Methotrexate / Q000494:pharmacology; D010926:Placental Hormones / Q000096:biosynthesis; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis*; D012333:RNA, Messenger / Q000096:biosynthesis; D014327:Trophoblasts / Q000378:metabolism*
chemical_list: D000199:Actins; D002087:Butyrates; D006063:Chorionic Gonadotropin; C064980:GH2 protein, human; D010926:Placental Hormones; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D020148:Butyric Acid; D013006:Growth Hormone; D008727:Methotrexate